Mads D.M. Engelmann

2.1k total citations · 2 hit papers
23 papers, 1.4k citations indexed

About

Mads D.M. Engelmann is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Nutrition and Dietetics. According to data from OpenAlex, Mads D.M. Engelmann has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Nutrition and Dietetics. Recurrent topics in Mads D.M. Engelmann's work include Iron Metabolism and Disorders (4 papers), Child Nutrition and Water Access (3 papers) and Infant Nutrition and Health (3 papers). Mads D.M. Engelmann is often cited by papers focused on Iron Metabolism and Disorders (4 papers), Child Nutrition and Water Access (3 papers) and Infant Nutrition and Health (3 papers). Mads D.M. Engelmann collaborates with scholars based in Denmark, United States and United Kingdom. Mads D.M. Engelmann's co-authors include Jesper Hastrup Svendsen, Kim F. Michaelsen, G. Kees Hovingh, Brittmarie Sandström, Florian M.M. Baeres, Dominic S. Raj, Michael Davidson, Paul M. Ridker, Douglas Kling and Peter Libby and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Mads D.M. Engelmann

21 papers receiving 1.4k citations

Hit Papers

IL-6 inhibition with ziltivekimab in patients at high ath... 2021 2026 2022 2024 2021 2025 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
    2021 433 citations Paul M. Ridker, Matt Devalaraja et al. The Lancet profile →
  2. Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
    2025 89 citations Darren K. McGuire, Nikolaus Marx et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mads D.M. Engelmann Denmark 12 471 270 264 247 244 23 1.4k
Daniele Longo United States 23 402 0.9× 215 0.8× 288 1.1× 171 0.7× 70 0.3× 48 2.0k
Rosalinda Posadas‐Sánchez Mexico 22 345 0.7× 380 1.4× 367 1.4× 300 1.2× 105 0.4× 136 1.7k
Jessie Shih United States 9 627 1.3× 703 2.6× 330 1.3× 484 2.0× 58 0.2× 13 1.8k
John‐Bjarne Hansen Norway 19 220 0.5× 114 0.4× 97 0.4× 173 0.7× 152 0.6× 41 939
Ashok K. Bhalla United Kingdom 10 114 0.2× 157 0.6× 249 0.9× 158 0.6× 195 0.8× 16 1.7k
Şule Şengül Türkiye 20 188 0.4× 255 0.9× 115 0.4× 172 0.7× 113 0.5× 93 1.2k
A. E. Evans United Kingdom 21 408 0.9× 230 0.9× 107 0.4× 630 2.6× 81 0.3× 36 1.8k
Savita Kumari India 16 234 0.5× 232 0.9× 71 0.3× 299 1.2× 72 0.3× 88 1.3k
Frank Stüber Germany 15 123 0.3× 430 1.6× 366 1.4× 234 0.9× 61 0.3× 29 1.3k
Pedro Valdivielso Spain 25 642 1.4× 324 1.2× 114 0.4× 856 3.5× 86 0.4× 143 2.0k

Countries citing papers authored by Mads D.M. Engelmann

Since Specialization
Citations

This map shows the geographic impact of Mads D.M. Engelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mads D.M. Engelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mads D.M. Engelmann more than expected).

Fields of papers citing papers by Mads D.M. Engelmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mads D.M. Engelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mads D.M. Engelmann. The network helps show where Mads D.M. Engelmann may publish in the future.

Co-authorship network of co-authors of Mads D.M. Engelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Mads D.M. Engelmann. A scholar is included among the top collaborators of Mads D.M. Engelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mads D.M. Engelmann. Mads D.M. Engelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perkovic, Vlado, Katherine R. Tuttle, Naveed Sattar, et al.. (2025). WCN25-888 DESIGN OF THE ZEUS TRIAL: INTERLEUKIN 6 INHIBITION WITH ZILTIVEKIMAB FOR CARDIOVASCULAR PROTECTION IN CHRONIC KIDNEY DISEASE. Kidney International Reports. 10(2). S767–S768. 6 indexed citations
2.
3.
Baeres, Florian M.M., Mads D.M. Engelmann, G. Kees Hovingh, et al.. (2025). Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial. JAMA Cardiology. 11(1). 89–89.
4.
McGuire, Darren K., Nikolaus Marx, Sharon L. Mulvagh, et al.. (2025). Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes. New England Journal of Medicine. 392(20). 2001–2012. 89 indexed citations breakdown →
5.
6.
Nyberg, Michael, et al.. (2022). A State of Natriuretic Peptide Deficiency. Endocrine Reviews. 44(3). 379–392. 10 indexed citations
7.
Skovgaard, Dorthe, Poul‐Martin Haahr, Katherine Clark, et al.. (2022). Prevalence of Baseline Cardiac Arrhythmias in Participants with Overweight or Obesity in Phase 1 Clinical Trials: Analysis of 24‐Hour Holter Electrocardiogram Recordings. The Journal of Clinical Pharmacology. 63(5). 539–543. 1 indexed citations
8.
Ridker, Paul M., Matt Devalaraja, Florian M.M. Baeres, et al.. (2021). IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet. 397(10289). 2060–2069. 433 indexed citations breakdown →
9.
10.
Engelmann, Mads D.M. & Jesper Hastrup Svendsen. (2005). Inflammation in the genesis and perpetuation of atrial fibrillation. European Heart Journal. 26(20). 2083–2092. 327 indexed citations
11.
Engelmann, Mads D.M., et al.. (2005). Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation. International Journal of Cardiology. 105(1). 31–39. 26 indexed citations
12.
Jeppesen, Dorthe Lisbeth, Hans Carl Hasselbalch, Ida Maria Lisse, Annette Kjær Ersbøll, & Mads D.M. Engelmann. (2004). T‐lymphocyte subsets, thymic size and breastfeeding in infancy. Pediatric Allergy and Immunology. 15(2). 127–132. 49 indexed citations
13.
Engelmann, Mads D.M., Steen Pehrson, Isaac Kobrin, et al.. (2003). Contents Vol. 3, 2003. 3(4). 241–242. 1 indexed citations
14.
Engelmann, Mads D.M. & J Godtfredsen. (2003). Assessment of Quality of Life in Pharmacological Treatment of Atrial Fibrillation. 3(1). 14–24. 3 indexed citations
15.
Hasselbalch, Hans Carl, Mads D.M. Engelmann, Annette Kjær Ersbøll, Dorthe Lisbeth Jeppesen, & Kim F. Michaelsen. (1999). Breast-feeding influences thymic size in late infancy. European Journal of Pediatrics. 158(12). 964–967. 55 indexed citations
16.
Engelmann, Mads D.M., Lena Davidsson, Brittmarie Sandström, et al.. (1998). The Influence of Meat on Nonheme Iron Absorption in Infants. Pediatric Research. 43(6). 768–773. 64 indexed citations
17.
Engelmann, Mads D.M., Brittmarie Sandström, & Kim F. Michaelsen. (1998). Meat Intake and Iron Status in Late Infancy: An Intervention Study. Journal of Pediatric Gastroenterology and Nutrition. 26(1). 26–33. 5 indexed citations
18.
Engelmann, Mads D.M., Brittmarie Sandström, & Kim F. Michaelsen. (1998). Meat Intake and Iron Status in Late Infancy: An Intervention Study. Journal of Pediatric Gastroenterology and Nutrition. 26(1). 26–33. 81 indexed citations
19.
Lisse, Ida Maria, et al.. (1997). T-lymphocyte subsets in West African children: Impact of age, sex, and season. The Journal of Pediatrics. 130(1). 77–85. 97 indexed citations
20.
Engelmann, Mads D.M., Brittmarie Sandström, & Kim F. Michaelsen. (1996). 108 THE EFFECT OF MEAT INTAKE ON IRON STATUS IN EIGHT TO TEN MONTHS OLD INFANTS. Journal of Pediatric Gastroenterology and Nutrition. 22(4). 436–436. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniele Longo Breakdown of academic impact, for papers by Rosalinda Posadas‐Sánchez Breakdown of academic impact, for papers by Jessie Shih Breakdown of academic impact, for papers by John‐Bjarne Hansen Breakdown of academic impact, for papers by Ashok K. Bhalla Breakdown of academic impact, for papers by Şule Şengül Breakdown of academic impact, for papers by A. E. Evans Breakdown of academic impact, for papers by Savita Kumari Breakdown of academic impact, for papers by Frank Stüber Breakdown of academic impact, for papers by Pedro Valdivielso
Rankless by CCL
2026